Triptorelin Acetate

Triptorelin acetate causes GnRH receptor desensitization, leading to reduced secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby modulating the hypothalamic-pituitary-gonadal (HPG) axis. These properties have made it a widely studied peptide in endocrine and reproductive research.

Triptorelin acetate has been extensively investigated in preclinical and clinical studies involving hormone-dependent conditions, including:

• Prostate cancer
• Breast cancer
• Endometriosis
• Central precocious puberty
• Assisted reproductive technologies

It continues to be evaluated for applications in endocrine therapies, fertility preservation, and reproductive health research.